Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting. It focuses on anxiety and currently lists participation information in Turkey.
In Ankara
This study is recruiting. It focuses on anxiety and currently lists participation information in Poland.
Multiple locations, including PoznanThis study is recruiting. It focuses on anxiety and currently lists participation information in China.
In ChinaThis study is recruiting. It focuses on anxiety and currently lists participation information in Canada.
In GuelphThis study is recruiting. It focuses on anxiety and currently lists participation information in Pakistan.
In LahoreThis study is recruiting in the United Kingdom. It focuses on anxiety.
In United KingdomThis study is recruiting. It focuses on anxiety and currently lists participation information in Turkey.
In AnkaraThis study is recruiting. It focuses on anxiety and currently lists participation information in Turkey.
In IstanbulThis study is recruiting in Netherlands. It focuses on anxiety.
In Netherlands
This study is recruiting. It focuses on anxiety and currently lists participation information in Turkey.
In MersinThis study is recruiting. It focuses on anxiety and currently lists participation information in Turkey.
In Mersin
This study is recruiting in China, in Malaysia, in Singapore, .... It is testing agomelatine (25-50 mg/day) for anxiety.
In China